Abstract
Lung cancer is the most common disease among cancer pathology. According to statistics, every year more than 2 million of new cases are registered around the world, of which about 60 000 in Russia. There is also a tendency of growth of the disease. According to various sources, approximately 85% of all lung cancers are non-small cell carcinomas (NSCLC). Tactics of its treatment and prognosis, in relation to the quality of life of the patient, depends on the accuracy and time (on the early stages) of detection of the disease. Radiation research methods are important in the diagnosis and staging of lung cancer. The treatment standards for NSCLC patients are based on the 1998 meta-analyses, which do not take into account the possibilities of modern radiotherapy, therefore, there is a need to reconsider the existing treatment standards, as mentioned in many articles by various authors.The development of clinical radiology is progressing rapidly. Every year the technology and efficiency of radiotherapy is improved, the total radiation load on the body is reduced. This, in turn, improves the quality of postoperative local control and increases overall and relapse-free survival. This review presents the most promising trends in NSCLC therapy.